← Back to Search

Mesh

Resorbable Mesh for Ventral Hernia (RECOVER Trial)

N/A
Recruiting
Research Sponsored by Medtronic - MITG
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subject is 18 years of age or older at the time of consent
Subject is undergoing a planned, elective, open, single-staged repair of a midline primary or incisional ventral hernia using retrorectus/retromuscular mesh placement with or without Transversus Abdominis Release (TAR)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at discharge (post-surgery up to 1-mo), and within 1, 6, 12, 24, 36, 48 and 60 months
Awards & highlights

Summary

"This trial is testing a new type of resorbable mesh called Transorb™ in patients at high risk for wound healing issues during hernia repair surgeries. The study will evaluate its effectiveness and safety in

Who is the study for?
This trial is for adults over 18 with a high risk of complications in wound healing, undergoing elective open repair of ventral hernia. Eligible participants include current or former heavy smokers, those with obesity (BMI between 30 and 39.9), and individuals with COPD. The surgery must involve retrorectus/retromuscular mesh placement, possibly including TAR.
What is being tested?
The RECOVER study tests the performance and safety of Transorb™ Self-Gripping Resorbable Mesh in reinforcing abdominal wall tissues during ventral hernia repair surgeries that are clean or clean-contaminated as per CDC guidelines.
What are the potential side effects?
While specific side effects aren't listed here, generally such surgical meshes may cause discomfort, inflammation at the site, infection risks, potential allergic reactions to materials used in the mesh or issues related to improper healing.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am scheduled for a specific surgery to repair a hernia in my abdomen using a special technique.
Select...
My wound is clean and not infected, according to CDC standards.
Select...
I have smoked (or used to smoke) at least 20 packs of cigarettes a year.
Select...
I have been diagnosed with COPD.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at discharge (post-surgery up to 1-mo), and within 1, 6, 12, 24, 36, 48 and 60 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and at discharge (post-surgery up to 1-mo), and within 1, 6, 12, 24, 36, 48 and 60 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in subject quality of life (QoL)
Change in subject-reported pain
Hospital length of inpatient stay
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hernia RepairExperimental Treatment1 Intervention
single arm study, no control arm

Find a Location

Who is running the clinical trial?

Medtronic - MITGLead Sponsor
256 Previous Clinical Trials
300,322 Total Patients Enrolled
20 Trials studying Hernia
3,272 Patients Enrolled for Hernia
Matthew Goldblatt, MD, FACSStudy ChairMedical College of Wisconsin
J. Scott Roth, MD, FACSStudy ChairUniversity of Kentucky
~109 spots leftby Mar 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top